103 results on '"Mureșanu, Dafin"'
Search Results
2. Nanowired Delivery of Mesenchymal Stem Cells with Antioxidant Compound H-290/51 Reduces Exacerbation of Methamphetamine Neurotoxicity in Hot Environment
3. Neuroprotective Effects of Nanowired Delivery of Cerebrolysin with Mesenchymal Stem Cells and Monoclonal Antibodies to Neuronal Nitric Oxide Synthase in Brain Pathology Following Alzheimer’s Disease Exacerbated by Concussive Head Injury
4. Nanowired Delivery of Cerebrolysin with Mesenchymal Stem Cells Attenuates Heat Stress-Induced Exacerbation of Neuropathology Following Brain Blast Injury
5. Co-administration of Nanowired DL-3-n-Butylphthalide (DL-NBP) Together with Mesenchymal Stem Cells, Monoclonal Antibodies to Alpha Synuclein and TDP-43 (TAR DNA-Binding Protein 43) Enhance Superior Neuroprotection in Parkinson’s Disease Following Concussive Head Injury
6. Co-administration of Nanowired Oxiracetam and Neprilysin with Monoclonal Antibodies to Amyloid Beta Peptide and p-Tau Thwarted Exacerbation of Brain Pathology in Concussive Head Injury at Hot Environment
7. TiO2-Nanowired Delivery of Chinese Extract of Ginkgo biloba EGb-761 and Bilobalide BN-52021 Enhanced Neuroprotective Effects of Cerebrolysin Following Spinal Cord Injury at Cold Environment
8. Nanodelivery of Histamine H3/H4 Receptor Modulators BF-2649 and Clobenpropit with Antibodies to Amyloid Beta Peptide in Combination with Alpha Synuclein Reduces Brain Pathology in Parkinson’s Disease
9. Co-Administration of Nanowired Monoclonal Antibodies to Inducible Nitric Oxide Synthase and Tumor Necrosis Factor Alpha Together with Antioxidant H-290/51 Reduces SiO2 Nanoparticles-Induced Exacerbation of Pathophysiology of Spinal Cord Trauma
10. Nanowired Delivery of Cerebrolysin Together with Antibodies to Amyloid Beta Peptide, Phosphorylated Tau, and Tumor Necrosis Factor Alpha Induces Superior Neuroprotection in Alzheimer’s Disease Brain Pathology Exacerbated by Sleep Deprivation
11. The psychological impact of the COVID-19 pandemic on people with multiple sclerosis
12. Interleukins (IL-23 and IL-27) serum levels: Relationships with gene polymorphisms and disease patterns in multiple sclerosis patients under treatment with interferon and glatiramer acetate
13. Beijing Declaration of International Association of Neurorestoratology (2023 Xi'an version)
14. The role of multiple sclerosis therapies on the dynamic of human gut microbiota
15. Structural connectivity in recovery after coma: Connectome atlas approach
16. The Modulation of Hippocampus Plasticity
17. Functional Connectivity and MRI Radiomics Biomarkers of Cognitive and Brain Reserve in Post-Stroke Cognitive Impairment Prediction—A Study Protocol.
18. Evolution of Cognitive Disorders in Patients with Mild Cognitive Impairment (MCI) After Ischemic Stroke: Secondary Data Analysis from the Improved Health Care in Neurology and Psychiatry—Longer Life (IHCNP) Study.
19. Neuropsychological Performance after Extended N-Pep-12 Dietary Supplementation in Supratentorial Ischemic Stroke.
20. Brain-Derived Neurotrophic Factor in Multiple Sclerosis Disability: A Prospective Study
21. Rare entrapment neuropathies of the lower extremity: A narrative review.
22. Memory-Guided Saccades in Subacute and Chronic Stroke: Secondary Data Analysis of the N-PEP-12 Clinical Study.
23. Non-Invasive Systems Application in Traumatic Brain Injury Rehabilitation
24. Diagnostic Approach to Lower Limb Entrapment Neuropathies: A Narrative Literature Review
25. Blink rate during saccadic eye movements: insights from patients with chronic pain.
26. Eye tracking assessment of Parkinson's disease: a clinical retrospective analysis.
27. Correlating Eye-Tracking Fixation Metrics and Neuropsychological Assessment after Ischemic Stroke
28. Biological Risk Factors Influencing Vascular Cognitive Impairments: A Review of the Evidence
29. The 2nd edition of the Romanian National Neurology Forum: from idea to implementation in the health system - here, now, together!
30. Unveiling the Future of Neurorehabilitation: Insights from the 18th Congress from the Society for the Study of Neuroprotection and Neuroplasticity (SSNN) in Conjunction with the WFNR-EFNR Central Asia Regional Meeting.
31. Quantitative EEG as a Biomarker in Evaluating Post-Stroke Depression
32. Clinical Utility of Boston-CTS and Six-Item CTS Questionnaires in Carpal Tunnel Syndrome Associated with Diabetic Polyneuropathy
33. Chapter Six - Nicotine neurotoxicity exacerbation following engineered Ag and Cu (50–60 nm) nanoparticles intoxication. Neuroprotection with nanowired delivery of antioxidant compound H-290/51 together with serotonin 5-HT3 receptor antagonist ondansetron
34. Chapter Five - Co-administration of dl-3-n-butylphthalide and neprilysin is neuroprotective in Alzheimer disease associated with mild traumatic brain injury
35. Chapter Two - Nanodelivery of histamine H3 receptor inverse agonist BF-2649 with H3 receptor antagonist and H4 receptor agonist clobenpropit induced neuroprotection is potentiated by antioxidant compound H-290/51 in spinal cord injury
36. Chapter One - Spinal cord injury induced exacerbation of Alzheimer's disease like pathophysiology is reduced by topical application of nanowired cerebrolysin with monoclonal antibodies to amyloid beta peptide, p-tau and tumor necrosis factor alpha
37. Chapter Three - Nanowired delivery of antibodies to tau and neuronal nitric oxide synthase together with cerebrolysin attenuates traumatic brain injury induced exacerbation of brain pathology in Parkinson’s disease
38. Chapter One - Stress induced exacerbation of Alzheimer’s disease brain pathology is thwarted by co-administration of nanowired cerebrolysin and monoclonal amyloid beta peptide antibodies with serotonin 5-HT6 receptor antagonist SB-399885
39. Chapter Four - Sleep deprivation enhances amyloid beta peptide, p-tau and serotonin in the brain: Neuroprotective effects of nanowired delivery of cerebrolysin with monoclonal antibodies to amyloid beta peptide, p-tau and serotonin
40. Steinert's disease, from assumption to certainty in neurological practice
41. Continuity in the Educational Approach: NeurotechEU Summer School of Quantitative Electroencephalography (QEEG) Second Edition in Cluj-Napoca.
42. Predictors of Short-Term Mortality in Patients with Ischemic Stroke.
43. POEMS syndrome misdiagnosed as CIDP: A case report.
44. The Effect of Cerebrolysin on Anxiety, Depression, and Cognition in Moderate and Severe Traumatic Brain Injury Patients: A CAPTAIN II Retrospective Trial Analysis
45. Eyes on dementia: an overview of the interplay between eye movements and cognitive decline.
46. Role and Impact of Cerebrolysin for Ischemic Stroke Care
47. 18th International Summer School of Neurology in conjunction with the 13th European Teaching Course on Neurorehabilitation.
48. Cluj hosts the first European Summer School of Quantitative Electroencephalography (QEEG) - Blended Intensive Program within the European University of Brain and Technology (NeurotechEU).
49. Chapter Two - REMOVED: Nanowired delivery of dl-3-n-butylphthalide with antibodies to alpha synuclein potentiated neuroprotection in Parkinson’s disease with emotional stress
50. Advancing clinical neuroscience in Romania: a decade of experience from the RoNeuro Institute for Neurological Research and Diagnostic.
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.